麻豆传媒

Prof. Nazeeruddin's current research at EPFL focuses on Perovskite Solar Cells and Light-emitting diodes. He has published more than 627 peer-reviewed papers, ten book chapters, and is an inventor/co-inventor of over 75 patents, which are well cited 87鈥�047 with an h-index of 137 having an average citation of over 141. Google Scholar h-index is 152, and total citations are 112鈥�012. His group has developed layer-by-layer growth of 3-dimensional and 2-dimensional perovskites yielding solar to the power conversion efficiency of 23.5% certified at Newport calibration PV lab earlier this year. His group has earned worldwide recognition and leadership in perovskite solar cells as evidenced by Times of higher Education selection as 鈥渢he top 10 researchers in the world working on the high impact perovskite materials and devices鈥�. This recognition is based on the accumulated results and impacts generated between 2014 and 2018. He is elected to the European Academy of Sciences (EURASC), and Fellow of The Royal Society of Chemistry. According to ISI listing, he is one of the most cited chemists in 2014, 2015, 2016, 2017 and 2018, and one of the 20 scientists identified by Thomson Reuters as The World Most Influential Scientific Minds 2015, 2017, and 2018 from all scientific domains. 

In the quest for molecular-level information, molecular-scale tools are a powerful and desirable scientific goal. Our research program is centered on development of a new class of nanofabricated devices based on nanopores.

In its simplest form, a nanopore is nothing more than a molecular-sized hole in an insulating membrane. Yet even in this configuration, it is cable of being used to detect and manipulate single molecules. With careful device engineering, it is possible to create powerful sensors for the detection of disease biomarkers at low levels early in the onset of disease or of trace amounts of toxins -- to name two targets. Configured differently, nanopore-based devices can be used to probe intermolecular interactions that underpin biological function -- ranging from testing new pharmaceutical drug candidates to exploring the fundamental biophysics governing processes such as antibody-antigen recognition.

Our research is focused on conceiving, fabricating and optimizing the nanopore devices that will make possible these challenging goals.

Research Interests include:

How do molecules work, and how can we better put them to work for us? Bioanalytical, biophysical, & materials chemistry and nanoscience.

Jin Kim Montclare is a Professor in the Department of Chemical and Biomolecular Engineering, who is performing groundbreaking research in engineering proteins to mimic nature and, in some cases, work better than nature. She works to customize artificial proteins with the aim of targeting human disorders, drug delivery and tissue regeneration as well as create nanomaterials for electronics. Using multidisciplinary expertise in chemistry and genetic engineering, these results have already been realized.

Prior to joining NYU-Tandon, Montclare was a postdoctoral fellow at the California Institute of Technology in the Division of Chemistry and Chemical Engineering.

She received a Bachelor of Science in Chemistry from Fordham University in 1997, a Master of Science and a Ph.D. in Bioorganic Chemistry from Yale University in 2001 and 2003, respectively.

Among her many honors and awards are the AAAS Leshner Fellowship, AIMBE Fellow, ACS Rising Star Award, Agnes Faye Morgan Research Award from Iota Sigma Pi, Executive Leadership in Academic Technology and Engineering Fellowship, American Chemical Society PROGRESS /Dreyfus Lectureship, the Dreyfus Special Grants Program Award, the Air Force Office of Scientific Research Young Investigator Award, the Wechsler Award for Excellence, the Othmer Junior Fellow Award, the National Institute鈥檚 of Health Postdoctoral Fellowship, and the National Science Foundation Pre-doctoral Fellowship.

Montclare is the author of numerous papers for refereed journals, colloquia, and seminars and holds several patents.

She is a member of the American Chemical Society, the International Society for Pharmaceutical Engineering, the Biophysical Society, the Materials Research Society, the Biochemical Society, the Protein Society and American Association of Cancer Research, and the American Institute of Chemical Engineers.

Computational chemist Christopher Hendon (aka Dr. Coffee) is an international expert on the science of coffee. He can talk about how to brew the best cup according to science.

He authored the book, 鈥淲ater For Coffee,鈥� with Maxwell Colonna-Dashwood, a world champion level barista. Together, the two have won barista championships and transformed the art and science of espresso worldwide. Hendon studies material properties that emerge from chemical imperfections. His work on these defects has applications in energy storage and conversion. Collaborating with colleagues from across disciplines, he鈥檚 looking for ways to create new designer materials that reduce the dependence on precious metals.

His coffee research has become a permanent fixture in the university. The Oregon Coffee Laboratory is a public laboratory where Hendon studies the electrical properties of coffee extracts. He continues to work with and support local businesses, while maximizing his research impact within the coffee industry.

Research Interests

Analytical Chemistry
Physical Chemistry
Biochemistry
Laser Spectroscopy

Dr. Karen W. Barnes received her P.h.D. in Chemistry from the University of Florida. Barnes spends additional time researching Food Analyses. She teaches Chemistry 2045 Lab and Chemistry 2046 Lab. 

Degrees & Institutions:
Ph.D., University of Florida, Gainesville, Florida
B.S., University of West Florida, Pensacola, Florida 

Research:
Barnes spends additional time researching Food Analyses.

Current Courses:
General Chemistry I Lab
General Chemistry II Lab
Analytical Chemistry
Analytical Chemistry Lab
Publications:
Barnes, K.W.; and C.J. Fields-Wolf, General Chemistry I Laboratory, University of West Florida, Pensacola, 2018. All royalties from this Laboratory Manual have been used to establish a UWF Chemistry scholarship.

Barnes, K.W.; and C.J. Fields-Wolf, General Chemistry II Laboratory, University of West Florida, Pensacola, 2018. All royalties from this Laboratory Manual have been used to establish a UWF Chemistry scholarship.

Dr. David Hoyt is a chemist with the  team. Hoyt has over 30 years of experience with research related to nuclear magnetic resonance (NMR) and other forms of spectroscopy. His research focus has been on the structure and dynamics of bio-complexes and metabolite identification via NMR. More recently, his interests have broadened to include biogeochemistry and NMR specialty-probe development projects. Hoyt has co-authored peer-reviewed publications in Nature Microbiology, Nature Communications, Nature Structural Biology, PNAS, Cell, ISME, Molecular Cell, JACS, Biochemistry, and Journal of Magnetic Resonance.
For 10 years Hoyt served in EMSL management and for over 25 years in technical support of the EMSL user program—providing research collaboration in high-field liquids NMR with structural biology and metabolomics applications, as well as in situ chemistry projects.
Hoyt was responsible to site and develop ~$12 million in new American Reinvestment and Recovery Act funded magnetic resonance systems between June 2009 and November 2011. He has also served as project manager of several recent procurements for PNNL. From 2002 to present he worked to site and develop over $40 million in NMR and electron paramagnetic resonance equipment with EMSL operations. This work included enhancements to in situ controlled-environment NMR and metabolomics capabilities. His leadership on the R&D team for high temperature and high-pressure NMR rotor capability development for in situ measurements of mixed-phased chemistry and biologics has recently led to licensing by Revolution NMR LLC (Fort Collins, CO). His present interests now include advancing PNNL and EMSL science through further work developing and participating in research and R&D of integrated capabilities related to biological, environmental, and molecular-interface contexts.

Dr. Chaevien Clendinen is an analytical chemist with the Biomolecular Pathways team. She is an expert in metabolomics data analysis and workflow development using a variety of analytical pipelines, including liquid chromatography mass spectrometry (LC-MS), gas chromatography MS (GC-MS), and nuclear magnetic resonance (NMR) spectroscopy. She is also an expert in structural elucidation using LC-MS and NMR.  
Clendinen has 10 years of research experience across multiple disciplines, including analytical and physical chemistry, microbiology and virology, cancer biology, and biotechnology. At EMSL, Dr. Clendinen assists users in the collection and analysis of metabolomics data from a variety of sample matrices. She is currently working with PNNL researchers to improve LC, GC, and NMR metabolomics workflows and identification confidence.

Dr. James Evans is a Chemist with the Structural Biology team. He supports the electron microscopy capabilities and develops new technologies and methods for in situ and dynamic multiscale and multimodal bioimaging. He oversees the operation of the cryo-transmission electron microscope (Krios G3i) with direct electron detector for structural biology applications. He is also integrating two Class IV pulsed lasers with a dual aberration corrected JEOL 2200FS to create a new dynamic transmission electron microscope, or DTEM, in the EMSL Quiet Wing. This unique instrument will enable pump-probe, high-resolution electron microscopy on the nanosecond to microsecond timescales to visualize biological macromolecular dynamics in real-time. 

Postdoctoral Scholar, University of California, Irvine
Visiting Scientist, California Institute of Technology
PhD, University of Delaware
BS, University of South Carolina



Biography
The Perrine research group focuses on understanding reactions and processes at surfaces and interfaces, from pure metals, oxides, minerals to heterogeneous materials. We use a surface chemistry and surface science approach to connect molecular-level reactions at the gas/solid and liquid/solid interface. We also design meso- and nano-architectured materials using surface functionalization methods for next-generation heterogeneous catalysts and materials. Our aim is to understand the fundamental physical and chemical processes at interfaces to unravel surface mechanisms and transformations of materials, addressing challenges in catalysis and environmental science.
A variety of surface analysis instruments are utilized to understand surface chemistry, including vibrational spectroscopy, electron spectroscopies, mass spectrometry, scanning electron microscopy, and atomic force microscopy. Our program is multidisciplinary encompassing the fields of chemistry, physics, materials science, and engineering. 



Links of Interest


Positions are open for undergraduate, masters, and PhD students.





Research Interests

Surface chemistry and interfacial science
Bridging reactions at the gas/solid and liquid/solid interfaces under model (ultra-high vacuum) and real (near ambient pressure) conditions
Designing metal-oxide architectures and nanostructures on various substrates; Atomic Layer Deposition and tailored growth approaches
Growth, properties, and reactions on heterogeneous structures for energy and environmental applications

Anton is a research and teaching academic, and the Applied Chemistry and Translational Biomaterials (ACTB) Group leader at the Clinical and Health Sciences (CHS) Unit at the University of South Australia (UniSA). His research group works at the interface between chemistry, biomaterials and pharmaceutical sciences to develop innovative solutions to current and emerging biomedical and environmental challenges. Anton also teaches into first year chemistry, and second year analytical and organic chemistry courses.    
The ACTB Group has a strong focus on the translation of fundamental principles to applied outputs and end-user informed solutions. Currently the group is collaborating with various biotech (Carina Biotech; Vetter Pharm.; D&R Pharm.; CRC CTM) and conservation (FAME; Ecological Horizons) groups to develop innovative technologies to deliver more efficient, efficacious and sustainable processes.  
After completing a PhD in Organic and polymer chemistry from the University of Reading (UK) under the supervision of Prof. Wayne Hayes in 2006, Anton joined the Polymer Science Group at the University of Melbourne as a Postdoctoral Fellow, where he worked on several CRCs (CRC for Polymers; Cotton Catchment Communities CRC) and ARC Linkage (DuPont; PolyActiva) funded projects. In 2009, he was awarded an Australian Research Council Postdoctoral Fellowship. In 2013, Anton moved to UniSA as a Senior Research Fellow to contribute and manage several CRC projects (Vision CRC; Wound Management Innovation CRC; CRC for Cell Therapy Manufacturing (CTM)), before joining Pharmacy School (now CHS) in 2015 to establish the ACTB Group.

Usha Rao is a recipient of the Association for Women in Science’s Zenith award, a lifetime leadership and achievement award. She has also received the Distinguished Research Lectureship from the Association for Women Geoscientists, and the Bingham Mentoring Award from the Philadelphia chapter of AWIS, awarded to a “distinguished scientist who has significantly influenced the advancement of women in science”. Dr. Rao was selected by Pennsylvania Governor Wolf to participate in the 'PA Women in STEM' video series. She serves as a writer and speaker on the environment, leadership, and mentoring for many US and international organizations. Some recent partners include the Chronicle of Higher Education, the Swiss National Science Foundation's PRIMA Program, the American Association for Environmental Engineering and Science, and Lab Manager magazine. 
Dr. Rao's STEM teaching has been recognized with the Lindback Foundation's Christian R. and Mary F. Lindback Medal for Distinguished University Teaching. She has also received three merit awards for "exceptional achievement in teaching" at Saint Joseph's University and was selected as a Most Valuable Professor (MVP) by the women's basketball team.
At Saint Joseph's, Dr. Rao co-developed the John P. McNulty Program for Leadership in Science and Mathematics, an initiative that has supported 130 emerging leaders since 2009. She also created the University’s first faculty development office to provide resources and mentoring to hundreds of faculty members, serving as the Founding Director. Dr. Rao’s board service includes the Ardmore Library of the Lower Merion Library System and the Frances M. Maguire Art Museum at the Barnes Foundation in Lower Merion.
Dr. Rao’s research focuses on water chemistry. She is a coordinating editor for Springer-Nature's Environmental Geochemistry and Health, the journal of the Society for Environmental Geochemistry and Health. She serves as an Approved Expert Reviewer for the Nobel-prize winning United Nations’ Intergovernmental Panel on Climate Change (UN IPCC) and as a Mentor for former US Vice President Gore’s Climate Reality initiative.
Her research at SJU has been funded by the National Science Foundation, the American Chemical Society Petroleum Research Fund, the Lindback Foundation Minority Research Program, Purdue University’s PRIME particle accelerator laboratory, the Michael J. Morris Grant Program, and Saint Joseph’s University Board on Faculty Development and Research. She is currently accepting queries from graduate students.

Dr. Rong Fan is the Harold Hodgkinson Professor of Biomedical Engineering and of Pathology. His research interest has been centered on the development and deployment of single-cell and spatial omics technologies to investigate normal development, aging, and disease. He received a B.S. in Applied Chemistry from University of Science and Technology of China, a Ph.D. in Chemistry from the University of California at Berkeley, and then completed his postdoctoral training at California Institute of Technology, prior to joining the faculty of Department of Biomedical Engineering at Yale University in 2010. He developed a microchip that allows for simultaneous measurement of 42 immune effector proteins in single cells at high throughput, which remains the highest multiplexing to date for a single-cell protein secretion assay. In collaboration with Novartis and Kite Pharma, it was applied to profiling antigen-specific activation states of chimeric antigen receptor (CAR)-engineered T cells, resulting in the discovery of novel single-cell biomarkers including polyfunctional strength index to characterize the quality of CAR-T infusion products and predict the clinical responses and immune-related adverse effects(irAEs) prior to treatment. This microchip, called IsoCode, and the automation system, called IsoLight, have been commercialized by IsoPlexis, a company co-founded by Dr. Fan. Now, this system has been used by >100 major pharmaceutical companies and cancer centers around the world for monitoring CAR-T or checkpoint inhibitor immunotherapies. Dr. Fan is also a pioneer in developing NGS-based spatial omics sequencing technologies. He conceived the concept of spatial multi-omics and developed the first spatially resolved multi-omics sequencing technology called DBiT-seq (Liu et al., Cell 183, 1665–1681, 2020) which allows for spatial co-profiling of whole transcriptome and hundreds of proteins (spatial-CITE-seq) at cellular level in complex tissues. He further developed a first-of-its-kind technology to enable spatial epigenome sequencing including spatial-ATAC-seq (Deng et al., Nature 609 (7926), 375-383, 2022) and spatial-CUT&Tag (Deng et al., Science 375 (6581), 681-686, 2022). These technologies may unlock a whole new field in spatial biology with applications in a wide range of biological and biomedical research. Dr. Fan co-founded IsoPlexis, Singleron Biotechnologies, and AtlasXomics. He is the recipient of multiple awards including the NCI Howard Temin Career Transition Award, the NSF CAREER Award, and the Packard Fellowship for Science and Engineering. He has been elected to American Institute for Medical and Biological Engineering (AIMBE), Connecticut Academy of Science and Engineering (CASE), and the National Academy of Inventors (NAI).

Prior to joining GFI, Nikhita worked in food and biotech product development, most recently as an Innovation Scientist at Beyond Meat. While at Beyond, she led flagship product development projects from the fundamental research stage through formulation and scale-up. She holds a bachelor’s degree in physics from the University of Illinois at Urbana-Champaign and a Ph.D. in materials science and engineering from Northwestern University.

Matt leads operations for the Good Food Institute’s Science and Technology Department, guiding U.S. and global strategies to accelerate alternative protein innovation. With 20 years of experience in research, academic publishing, and science leadership, he specializes in the environmental impacts of the food system, nanotechnology, and water treatment. He holds a bachelor’s degree in chemistry from the University of Notre Dame, a master’s in environmental engineering from Rice University, and a doctorate in environmental engineering from Duke University. Matt is passionate about advancing science to improve the taste, nutrition, and affordability of alternative proteins while building a more sustainable food system.